Literature DB >> 18460288

Magnetic resonance imaging in the assessment of ventricular remodeling and viability.

Michael Jerosch-Herold1, Raymond Y Kwong.   

Abstract

Cardiovascular MRI has effectively become a reference standard for quantifying ventricular volumes and function and for measuring the myocardial scar burden after myocardial infarction. Imaging of late gadolinium enhancement and microvascular obstruction carries strong prognostic information for identifying patients who would benefit from anti-remodeling therapy. The combination of gadolinium enhancement, perfusion, and cine imaging should make MRI the modality of choice in the assessment of left ventricular dysfunction and remodeling. The use of MRI in clinical trials of heart failure could help reduce sample size requirements because of its accuracy and reproducibility. This review describes the use of MRI in assessing ventricular remodeling and viability and summarizes the few studies that have relied on MRI for image-based markers of ventricular remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460288      PMCID: PMC3955037          DOI: 10.1007/s11897-008-0002-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  38 in total

Review 1.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

2.  Acute myocardial infarction: myocardial viability assessment in patients early thereafter comparison of contrast-enhanced MR imaging with resting (201)Tl SPECT. Single photon emission computed tomography.

Authors:  Kakuya Kitagawa; Hajime Sakuma; Tadanori Hirano; Shinya Okamoto; Katsutoshi Makino; Kan Takeda
Journal:  Radiology       Date:  2003-01       Impact factor: 11.105

3.  Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging.

Authors:  Heiko Mahrholdt; Anja Wagner; Thomas A Holly; Michael D Elliott; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

4.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.

Authors:  N G Bellenger; L C Davies; J M Francis; A J Coats; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

5.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

6.  Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.

Authors:  B A Groenning; J C Nilsson; L Sondergaard; T Fritz-Hansen; H B Larsson; P R Hildebrandt
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

7.  Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.

Authors:  David Bello; Dipan J Shah; George M Farah; Silvia Di Luzio; Michele Parker; Maryl R Johnson; William G Cotts; Francis J Klocke; Robert O Bonow; Robert M Judd; Mihai Gheorghiade; Raymond J Kim
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

8.  Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging.

Authors:  Gunnar K Lund; Alexander Stork; Kai Muellerleile; Achim A Barmeyer; Martin P Bansmann; Meike Knefel; Ulrike Schlichting; Martin Müller; Pablo E Verde; Gerhard Adam; Thomas Meinertz; Maythem Saeed
Journal:  Radiology       Date:  2007-10       Impact factor: 11.105

Review 9.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

10.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

View more
  3 in total

Review 1.  Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease.

Authors:  A Baritussio; A Scatteia; C Bucciarelli-Ducci
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-18       Impact factor: 2.357

2.  Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners.

Authors:  Fabio S Raman; Nadine Kawel-Boehm; Neville Gai; Melanie Freed; Jing Han; Chia-Ying Liu; Joao A C Lima; David A Bluemke; Songtao Liu
Journal:  J Cardiovasc Magn Reson       Date:  2013-07-26       Impact factor: 5.364

Review 3.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Authors:  Jessica Lohrke; Thomas Frenzel; Jan Endrikat; Filipe Caseiro Alves; Thomas M Grist; Meng Law; Jeong Min Lee; Tim Leiner; Kun-Cheng Li; Konstantin Nikolaou; Martin R Prince; Hans H Schild; Jeffrey C Weinreb; Kohki Yoshikawa; Hubertus Pietsch
Journal:  Adv Ther       Date:  2016-01-25       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.